Additionally, higher expression of UNC93B1 also a poor survival factor in AML patients with normal karyotype (HR: 2.29, p = 0.008, Figure 2F), which is predominant in intermediate-risk group (Lin et al., 2017). This evidence concerns the gene UNC93B1 and acute myeloid leukemia.